QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Dynavax Technologies Corp. (DVAX) Chief Scientific Officer Dr. Tim R. Mossman Receives Novartis Prize For Basic Immunology 0 comments
    Jun 20, 2013 10:30 AM | about stocks: DVAX

    Clinical-stage biopharmaceutical company Dynavax Technologies has announced that Dr. Robert L. Coffman, the company's chief scientific officer, and his former collaborator, Dr. Tim R. Mossman, have been awarded the 2013 Novartis Prize for Basic Immunology for their pioneering research defining subsets of immune system T cells that have advanced the understanding of infectious, autoimmune, and allergic diseases.

    In the 1980s, while working collaboratively at DNAX Research Institute in Palo Alto, Calif., Coffman and Mossman determined the distinct functions of two T-helper cell subsets: Th1 cells, which play a significant role in cellular immunity that is critical for resistance to infections; and Th2 cells, which can induce allergic diseases. The two doctors also discovered that dysregulation of Th1 and Th2 cell functions was implicated in various immunological diseases.

    The fundamental discovery made by Mossman and Coffman, regarding the specific types of T cells that helped either cellular or humoral (antibody-mediated) immunity, changed the way the immune system's workings are understood and also led to major advances in the design of therapies for infectious, inflammatory and allergic diseases, as well as in vaccine design.

    The award ceremony for the Novartis Prize will take place on Aug. 23 at the 15th International Congress of Immunology, held in Milan, Italy. The Novartis Prizes for Immunology, established in 1990, are awarded every three years for groundbreaking contributions to the fields of basic and clinical immunology, as judged by an independent panel of experts.

    For more information about Dynavax, visit dynavax.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: DVAX
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.